Capitol Health Ltd
Capitol Health Limited provides diagnostic imaging modalities and related services to the healthcare market in Australia. It offers a range of diagnostic imaging services, including general x-ray, magnetic resonance imaging, ultrasound, mammography, Doppler, orthopantomogram, echocardiography, computed tomography, CT angiography, cone beam CT, nuclear medicine, bone densitometry, and fluoroscopy.… Read more
Market Cap & Net Worth: Capitol Health Ltd (CAJ)
Capitol Health Ltd (AU:CAJ) has a market capitalization of $255.80 Million (AU$413.13 Million) as of March 19, 2026. Listed on the AU stock exchange, this Australia-based company holds position #14483 globally and #192 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Capitol Health Ltd's stock price AU$0.39 by its total outstanding shares 1073059968 (1.07 Billion).
Capitol Health Ltd Market Cap History: 2015 to 2024
Capitol Health Ltd's market capitalization history from 2015 to 2024. Data shows change from $145.64 Million to $255.80 Million (-0.71% CAGR).
Index Memberships
Capitol Health Ltd is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Australia All Ordinaries
AORD
|
$470.71 Billion | 0.05% | #117 of 495 |
Weight: Capitol Health Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Capitol Health Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Capitol Health Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.09x
Capitol Health Ltd's market cap is 1.09 times its annual revenue
0.68x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $145.64 Million | $110.22 Million | $3.86 Million | 1.32x | 37.70x |
| 2016 | $67.64 Million | $104.28 Million | $1.68 Million | 0.65x | 40.17x |
| 2017 | $150.82 Million | $107.36 Million | $1.74 Million | 1.40x | 86.48x |
| 2018 | $144.51 Million | $119.03 Million | -$11.06 Million | 1.21x | N/A |
| 2019 | $126.24 Million | $149.24 Million | $27.53 Million | 0.85x | 4.58x |
| 2020 | $160.19 Million | $153.79 Million | $865.00K | 1.04x | 185.19x |
| 2021 | $233.48 Million | $178.00 Million | $11.92 Million | 1.31x | 19.59x |
| 2022 | $197.20 Million | $184.16 Million | $10.73 Million | 1.07x | 18.38x |
| 2023 | $151.16 Million | $209.59 Million | -$11.39 Million | 0.72x | N/A |
| 2024 | $255.80 Million | $234.82 Million | -$14.85 Million | 1.09x | N/A |
Competitor Companies of CAJ by Market Capitalization
Companies near Capitol Health Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Capitol Health Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #93 globally with a market cap of $174.19 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #150 globally with a market cap of $120.45 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #468 globally with a market cap of $45.61 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #507 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #93 | Thermo Fisher Scientific Inc | NYSE:TMO | $174.19 Billion | $464.69 |
| #150 | Danaher Corporation | NYSE:DHR | $120.45 Billion | $191.50 |
| #468 | IDEXX Laboratories Inc | NASDAQ:IDXX | $45.61 Billion | $577.12 |
| #507 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Capitol Health Ltd Historical Marketcap From 2015 to 2024
Between 2015 and today, Capitol Health Ltd's market cap moved from $145.64 Million to $ 255.80 Million, with a yearly change of -0.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | AU$255.80 Million | +69.23% |
| 2023 | AU$151.16 Million | -23.35% |
| 2022 | AU$197.20 Million | -15.54% |
| 2021 | AU$233.48 Million | +45.75% |
| 2020 | AU$160.19 Million | +26.89% |
| 2019 | AU$126.24 Million | -12.64% |
| 2018 | AU$144.51 Million | -4.19% |
| 2017 | AU$150.82 Million | +122.99% |
| 2016 | AU$67.64 Million | -53.56% |
| 2015 | AU$145.64 Million | -- |
End of Day Market Cap According to Different Sources
On Dec 22nd, 2025 the market cap of Capitol Health Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $255.80 Million USD |
| MoneyControl | $255.80 Million USD |
| MarketWatch | $255.80 Million USD |
| marketcap.company | $255.80 Million USD |
| Reuters | $255.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.